Medtronic launches world's first and only infusion set for insulin pumps that doubles wear time up to 7 days in u.s.

Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with medtronic extended infusion set dublin , nov. 15, 2022 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced the u.s. launch of medtronic extended infusion set, the first and only infusion set labelled for up to 7-day wear. an infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
MDT Ratings Summary
MDT Quant Ranking